Nurix Therapeutics Inc (NRIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NRIX | AZN | AMGN | GILD | VRTX |
| Company | Nurix Therapeutics Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 19.47 | 92.32 | 330.72 | 125.71 | 459.39 |
| High | 19.84 | 92.59 | 333.38 | 126.14 | 463.87 |
| Low | 19.31 | 92.01 | 330.72 | 125.12 | 459.08 |
| Latest | 19.37 | 92.50 | 332.87 | 125.97 | 463.19 |
| Change | +0.08 | +0.36 | +1.38 | +0.78 | +3.98 |
| % Change | +0.41% | +0.39% | +0.42% | +0.62% | +0.87% |
| Volume | 137,501 | 359,027 | 135,438 | 488,934 | 83,122 |
| 20-Day Average Volume | 2,003,289 | 5,492,741 | 3,073,077 | 7,073,280 | 1,401,600 |
| Previous Close | 19.29 | 92.14 | 331.49 | 125.19 | 459.21 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 18.53 | 91.07 | 329.64 | 122.84 | 448.45 |
| 20-Day Raw Stochastic | 54.01% | 65.68% | 61.24% | 77.33% | 99.27% |
| 20-Day Relative Strength | 65.25 | 60.14 | 56.94 | 56.82 | 62.15 |
| Weighted Alpha | +23.87 | +42.58 | +27.54 | +32.77 | +14.39 |
| Today's Opinion | 100% Buy | 100% Buy | 88% Buy | 96% Buy | 72% Buy |
| Previous Opinion | 100% Buy | 100% Buy | 88% Buy | 96% Buy | 72% Buy |
| Last Month's Opinion | 72% Buy | 100% Buy | 100% Buy | 100% Buy | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +7.19% since 12/17/25 | +2.82% since 12/17/25 | +2.21% since 12/17/25 | +3.74% since 12/17/25 | +3.13% since 12/17/25 |
| Low | 17.44 on 12/18/25 | 90.19 on 12/18/25 | 321.91 on 12/18/25 | 120.93 on 12/18/25 | 445.41 on 12/18/25 |
| High | 19.84 on 12/24/25 | 93.10 on 12/23/25 | 333.67 on 12/23/25 | 127.41 on 12/23/25 | 463.87 on 12/24/25 |
| 1-Month | |||||
| %Chg | +13.82% since 11/24/25 | +0.95% since 11/24/25 | -0.33% since 11/24/25 | +0.50% since 11/24/25 | +9.33% since 11/24/25 |
| Low | 16.02 on 12/02/25 | 89.28 on 12/12/25 | 312.39 on 12/11/25 | 118.17 on 12/16/25 | 423.45 on 12/01/25 |
| High | 22.50 on 12/08/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.16 on 11/26/25 | 463.87 on 12/24/25 |
| 3-Month | |||||
| %Chg | +124.37% since 09/24/25 | +22.60% since 09/24/25 | +19.33% since 09/24/25 | +10.75% since 09/24/25 | +23.09% since 09/24/25 |
| Low | 8.22 on 09/25/25 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 377.02 on 09/25/25 |
| High | 22.50 on 12/08/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.87 on 12/24/25 |
| 6-Month | |||||
| %Chg | +63.07% since 06/24/25 | +30.98% since 06/24/25 | +20.08% since 06/24/25 | +17.44% since 06/24/25 | +2.95% since 06/24/25 |
| Low | 8.19 on 09/23/25 | 68.61 on 07/21/25 | 269.77 on 09/26/25 | 104.46 on 06/25/25 | 362.50 on 08/11/25 |
| High | 22.50 on 12/08/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,483,073 | 285,767,776 | 178,501,056 | 155,320,736 | 116,510,304 |
| Shares Outstanding, K | 76,883 | 3,101,452 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 54,550,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -193,570,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 7,890,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -86,420,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 1.87 | 0.32 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.03 on 10/09/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 01/27/26 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.03 | 15.15 | 15.16 | 30.07 |